• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症和视神经脊髓炎患者脑脊液的蛋白质组学分析。

Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.

机构信息

Department of Neurology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, PR China.

出版信息

Mol Med Rep. 2012 Nov;6(5):1081-6. doi: 10.3892/mmr.2012.1025. Epub 2012 Aug 8.

DOI:10.3892/mmr.2012.1025
PMID:22895575
Abstract

The present study aimed to compare the 2-dimensional (2D) electrophoresis pattern of the cerebrospinal fluid (CSF) in multiple sclerosis (MS), neuromyelitis optica (NMO) and control individuals, to identify the proteins with differential expression and to examine their significance. CSF samples from the three groups were collected and total protein was isolated and quantified using the Bradford method. 2D electrophoresis of the samples was conducted using equal amounts of CSF. In the CSF 2D gel electrophoresis map, 118 points were obtained from the MS group, 155 points from the NMO group and 350 points from the normal control group. Non-matching proteins appeared in 14 spots in the MS group and in 45 spots in the NMO group, and were also expressed in the 2D electrophoresis pattern of the normal control group. Four differential proteins were identified through the HD-MS/MS and MASCOT network search. Pre-albumin (PA) was found only in the CSF 2D gel electrophoresis map of the MS patients. Keratin 1 was expressed in the normal control group, but not in the MS group. The difference in the expression of keratin 9 in the MS group was twice that in the normal control group. The expression of keratin 1, keratin 9 and transferrin in the NMO group was twice that in the normal control group. The expression of PA was found only in the CSF 2D gel electrophoresis map of the MS patients, and not in the NMO group. Keratin 1 was expressed in the NMO group, but not in the MS group. The expression of a variety of proteins in the 2D electrophoresis pattern of CSF was significantly different in the MS, NMO and control groups. PA, keratin 1, transferrin and keratin 9 are identified as significantly differentially expressed proteins.

摘要

本研究旨在比较多发性硬化症(MS)、视神经脊髓炎(NMO)和对照组患者的脑脊液(CSF)2 维电泳图谱,鉴定差异表达蛋白,并探讨其意义。收集三组 CSF 标本,采用 Bradford 法分离和定量总蛋白。用等量 CSF 进行 2D 电泳。在 CSF 2D 凝胶电泳图谱中,MS 组获得 118 个点,NMO 组获得 155 个点,正常对照组获得 350 个点。MS 组有 14 个点、NMO 组有 45 个点出现非匹配蛋白,且在正常对照组 2D 电泳图谱中也有表达。通过 HD-MS/MS 和 MASCOT 网络搜索鉴定出 4 种差异蛋白。前白蛋白(PA)仅在 MS 患者的 CSF 2D 凝胶电泳图谱中出现。角蛋白 1在正常对照组中表达,但在 MS 组中不表达。MS 组角蛋白 9 的表达差异是正常对照组的两倍。角蛋白 1、角蛋白 9 和转铁蛋白在 NMO 组的表达是正常对照组的两倍。PA 仅在 MS 患者的 CSF 2D 凝胶电泳图谱中出现,而在 NMO 组中未出现。角蛋白 1在 NMO 组中表达,但在 MS 组中不表达。MS、NMO 和对照组 CSF 2D 电泳图谱中多种蛋白的表达差异显著。PA、角蛋白 1、转铁蛋白和角蛋白 9 被鉴定为差异显著表达蛋白。

相似文献

1
Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.多发性硬化症和视神经脊髓炎患者脑脊液的蛋白质组学分析。
Mol Med Rep. 2012 Nov;6(5):1081-6. doi: 10.3892/mmr.2012.1025. Epub 2012 Aug 8.
2
Proteomics comparison of the sera from multiple sclerosis patients and neuromyelitis optica patients.
Genet Mol Res. 2014 Feb 14;13(4):9292-9. doi: 10.4238/2014.February.14.3.
3
Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.视神经脊髓炎和多发性硬化症中脑脊液CD59水平升高。
Clin Chim Acta. 2016 Jan 30;453:131-3. doi: 10.1016/j.cca.2015.12.013. Epub 2015 Dec 11.
4
Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.复发期间,多发性硬化症和视神经脊髓炎患者脑脊液中的尿胰蛋白酶抑制剂水平降低。
Neurochem Int. 2015 Feb;81:28-31. doi: 10.1016/j.neuint.2014.12.008. Epub 2014 Dec 30.
5
CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica.脑脊液高迁移率族蛋白 B1 与视神经脊髓炎的鞘内炎症和星形胶质细胞损伤有关。
J Neurol Neurosurg Psychiatry. 2013 May;84(5):517-22. doi: 10.1136/jnnp-2012-304039. Epub 2012 Dec 19.
6
Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.多发性硬化症和视神经脊髓炎患者脑脊液中甲状腺原氨酸和神经生长因子的水平
Neuro Endocrinol Lett. 2009 Mar;30(1):85-90.
7
Blood-brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability.与多发性硬化症相比,视神经脊髓炎中的血脑屏障破坏更为严重,且与临床残疾相关。
J Int Med Res. 2012;40(4):1483-91. doi: 10.1177/147323001204000427.
8
Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.视神经脊髓炎和多发性硬化症患者脑脊液中的白细胞介素 21 水平。
Can J Neurol Sci. 2012 Nov;39(6):813-20. doi: 10.1017/s0317167100015663.
9
Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.分析视神经脊髓炎和多发性硬化患者脑脊液和血清中触珠蛋白的水平。
Clin Chim Acta. 2013 Feb 18;417:26-30. doi: 10.1016/j.cca.2012.12.008. Epub 2012 Dec 21.
10
Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients.视神经脊髓炎患者脑脊液中生物标志物的蛋白质组分析。
Mol Vis. 2009 Aug 19;15:1638-48.

引用本文的文献

1
Brain Proteome Profiling Reveals Common and Divergent Signatures in Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.脑蛋白质组分析揭示帕金森病、多系统萎缩和进行性核上性麻痹中的共同和不同特征。
Mol Neurobiol. 2025 Mar;62(3):2801-2816. doi: 10.1007/s12035-024-04422-y. Epub 2024 Aug 21.
2
Microglial type I interferon signaling mediates chronic stress-induced synapse loss and social behavior deficits.小胶质细胞I型干扰素信号传导介导慢性应激诱导的突触丧失和社会行为缺陷。
Mol Psychiatry. 2025 Feb;30(2):423-434. doi: 10.1038/s41380-024-02675-6. Epub 2024 Aug 2.
3
Diagnostic Potential of Two Novel Biomarkers for Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis.
两种新型生物标志物对视神经脊髓炎谱系障碍和多发性硬化症的诊断潜力
Diagnostics (Basel). 2023 Apr 27;13(9):1572. doi: 10.3390/diagnostics13091572.
4
A differential proteomics study of cerebrospinal fluid from individuals with Niemann-Pick disease, Type C1.尼曼-匹克病 C1 型患者脑脊液的差异蛋白质组学研究。
Proteomics. 2023 Jun;23(11):e2200378. doi: 10.1002/pmic.202200378. Epub 2023 Jan 26.
5
Proteomics of Multiple Sclerosis: Inherent Issues in Defining the Pathoetiology and Identifying (Early) Biomarkers.多发性硬化症的蛋白质组学:定义病理生理学和识别(早期)生物标志物所固有的问题。
Int J Mol Sci. 2021 Jul 9;22(14):7377. doi: 10.3390/ijms22147377.
6
Metabolomic Profiling in Neuromyelitis Optica Spectrum Disorder Biomarker Discovery.视神经脊髓炎谱系障碍生物标志物发现中的代谢组学分析
Metabolites. 2020 Sep 18;10(9):374. doi: 10.3390/metabo10090374.
7
Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology.阿尔茨海默病患者无痴呆期的突触后蛋白组。
J Alzheimers Dis. 2018;65(2):659-682. doi: 10.3233/JAD-180179.
8
Utility of Two-Dimensional Difference Gel Electrophoresis in Diagnosis of Multiple Sclerosis.二维差异凝胶电泳在多发性硬化症诊断中的应用
Diagnostics (Basel). 2018 Jul 5;8(3):44. doi: 10.3390/diagnostics8030044.
9
Variations in the cerebrospinal fluid proteome following traumatic brain injury and subarachnoid hemorrhage.创伤性脑损伤和蛛网膜下腔出血后脑脊液蛋白质组的变化。
Pathophysiology. 2017 Sep;24(3):169-183. doi: 10.1016/j.pathophys.2017.04.003. Epub 2017 May 13.
10
Markers of oxidative/nitrative damage of plasma proteins correlated with EDSS and BDI scores in patients with secondary progressive multiple sclerosis.血浆蛋白氧化/硝化损伤标志物与继发进展型多发性硬化患者的 EDSS 和 BDI 评分相关。
Redox Rep. 2017 Nov;22(6):547-555. doi: 10.1080/13510002.2017.1325571. Epub 2017 May 19.